To the Editor,

The 2019 novel coronavirus (2019-nCoV, COVID-19) has spread in nearly 100 countries, infected 217,645 patients, and resulted in 8942 deaths worldwide. The major clinical feature is Respiratory Distress Syndrome and one key complication is Acute Cardiac Injury \[[@bb0005]\]. Interestingly, a recent article of *IJC* may provide a clue to heart protection for COVID-19-infected individuals, based on the oxidative stress theory \[[@bb0010]\].

According to recent clinical reports, the therapeutic time for COVID-19 infection is much longer than 14 days, but long-time viral stimulation is prone to suddenly elicit intensive immunological reactions, cytokine storm and immune-cell infiltration *in vivo*; however, some immunocytes especially macrophages and neutrophils can produce numerous reactive oxygen species (ROS) including H~2~O~2~, (·O~2~ ^−^), (·OH), etc. \[[@bb0010], [@bb0015], [@bb0020]\].

Generally, a certain level of ROS is important for regulating immunological responses and for clearing viruses, but excessive ROS will oxidize cellular proteins and membrane lipids and quickly destroy not only virus-infected cells but also normal cells in lung and even heart, resulting in multiple organ failure.

Thus, a potential anti-oxidative therapy could be proposed to alleviate cardiogenic casualties caused by COVID-19. Inexpensive medicinal antioxidants include Vitamin C (ascorbic acid) and Vitamin E, because their reductive hydrogen atoms can react with ROS and then produce nontoxic water \[[@bb0025]\]. Plant-derived molecules (similar to ancient Chinese medicine), such as Curcumin and Baicalin, may have potential anti-oxidative efficacy, too.

Predictably, a proper dose of antioxidants may ameliorate cardiac injuries of critically ill COVID-19-infected patients (but possibly not including mild-symptom patients).
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